CREDIT FACILITY AGREEMENTS - Additional Information (Details) $ in Thousands	1 Months Ended	3 Months Ended		9 Months Ended		12 Months Ended
	Apr. 30, 2024 USD ($) tranche	Sep. 30, 2025 USD ($)	Sep. 30, 2024 USD ($)	Sep. 30, 2025 USD ($)	Sep. 30, 2024 USD ($)	Dec. 31, 2024 USD ($)
Debt Instrument [Line Items]
Principal outstanding		$ 75,000		$ 75,000		$ 75,000
Loss on debt extinguishment		$ 0	$ 0	$ 0	$ 1,944	$ 1,900
Line of Credit
Debt Instrument [Line Items]
End of term charge	$ 1,400
End of term charge, interest rate (as a percent)	4.75%
Principal outstanding	$ 30,000
Effective interest rate (as a percent)		12.30%	13.37%	12.30%	13.37%
Line of Credit | Prime Rate | Maximum
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	11.45%
Pharmakon Credit Facility, Tranche One | Line of Credit
Debt Instrument [Line Items]
Draw on credit facility	$ 75,000
Credit facility, aggregate principal amount	25,000
Pharmakon Credit Facility | Line of Credit
Debt Instrument [Line Items]
Net proceeds	$ 39,600
Potential additional tranches | tranche	3
Tranches with minimum net sales milestones | tranche	2
Number of remaining additional tranches | tranche	1
Pharmakon Credit Facility | Line of Credit | Secured Overnight Financing Rate (SOFR)
Debt Instrument [Line Items]
Basis spread on variable rate (as a percent)	6.75%
Interest rate floor (as a percent)	3.75%
Pharmakon Credit Facility, Tranche Two | Line of Credit
Debt Instrument [Line Items]
Credit facility, aggregate principal amount	$ 50,000
Pharmakon Credit Facility, Tranche Three | Line of Credit
Debt Instrument [Line Items]
Credit facility, aggregate principal amount	$ 50,000